Our mechanistic studies revealed that STEAP4+ myoCAF represent a distinct subtype associated with ENZ resistance in prostate cancer and indicated that TFE3 plays a pivotal role in this resistance mechanism. The gene discussed is STEAP4; the disease is prostate cancer.